These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21614920)

  • 1. Aggressive ovarian psammocarcinoma: a case report.
    Zakkouri FA; Berrada N; Kettani F; Mrabti H; Jalil A; Errihani H
    Eur J Gynaecol Oncol; 2011; 32(2):214-5. PubMed ID: 21614920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian psammocarcinoma with peritoneal implants.
    Cobellis L; Pezzani I; Cataldi P; Bome A; Santopietro R; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2003 Apr; 107(2):217-9. PubMed ID: 12648875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enormous cystic tumor of peritoneal psammocarcinoma exhibiting complete response to Cisplatin and cyclophosphamide after suboptimal cytoreduction: case report and review of the literature.
    Takahashi R; Ueda Y; Shioji M; Adachi S; Ohashi H; Morii E; Aozasa K; Yoshino K; Fujita M; Enomoto T; Kimura T; Tokuhira A
    Gynecol Obstet Invest; 2012; 74(2):165-70. PubMed ID: 22584287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psammocarcinoma with an aggressive course.
    Poggi SH; Bristow RE; Nieberg RK; Berek JS
    Obstet Gynecol; 1998 Oct; 92(4 Pt 2):659-61. PubMed ID: 9764653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomyxoma Peritonei arising from a mucinous borderline ovarian tumour: Case report and literature review.
    Saluja M; Kenwright DN; Keating JP
    Aust N Z J Obstet Gynaecol; 2010 Aug; 50(4):399-403. PubMed ID: 20716272
    [No Abstract]   [Full Text] [Related]  

  • 6. Aggressive Serous Peritoneal Psammocarcinoma: a Case Report.
    Colonval P; Boven C; Oana M
    Acta Chir Belg; 2015; 115(6):426-8. PubMed ID: 26763843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: Incidental discovery of primary peritoneal psammocarcinoma.
    Helal I; Khanchel F; Jouini R; Ben Thayer M; Mbarki C; Bettaieb H; Rebii S; Ben Ismail I; Ben Brahim E; Chedli-Debbiche A
    F1000Res; 2022; 11():696. PubMed ID: 39233872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients.
    Fader AN; von Gruenigen V; Gibbons H; Abushahin F; Starks D; Markman M; Belinson J; Rose P
    Gynecol Oncol; 2008 Apr; 109(1):33-8. PubMed ID: 18261784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary psammocarcinoma of the ovary or peritoneum.
    Poujade O; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
    Int J Gynecol Cancer; 2009 Jul; 19(5):844-6. PubMed ID: 19574771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conservative surgery in a young patient with peritoneal psammocarcinoma.
    Munkarah AR; Jacques SM; Qureshi F; Deppe G
    Gynecol Oncol; 1999 May; 73(2):312-4. PubMed ID: 10329052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal psammocarcinoma diagnosed by a Papanicolau smear: a case report.
    Riboni F; Giana M; Piantanida P; Vigone A; Surico N; Boldorini R
    Acta Cytol; 2010; 54(3):311-3. PubMed ID: 20518416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique case of ovarian psammocarcinoma with mediastinal, pulmonary, subcutaneous, and omental metastases.
    Chase DM; Sparks DA; Gener M; Smith J
    Arch Gynecol Obstet; 2009 Aug; 280(2):283-6. PubMed ID: 19096859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel/carboplatin versus cyclophosphamide/carboplatin in peritoneal carcinomatosis of the ovary.
    Balat O
    Eur J Gynaecol Oncol; 2004; 25(2):195-6. PubMed ID: 15032280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of stage III or IV primary peritoneal serous papillary carcinoma.
    Dubernard G; Morice P; Rey A; Camatte S; Fourchotte V; Thoury A; Pomel C; Pautier P; Lhommé C; Duvillard P; Castaigne D
    Eur J Surg Oncol; 2004 Nov; 30(9):976-81. PubMed ID: 15498644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serous psammocarcinoma of the ovary: an unusual finding.
    Rettenmaier MA; Goldstein BH; Epstein HD; Brown JV; Micha JP
    Gynecol Oncol; 2005 Nov; 99(2):510-1. PubMed ID: 16051342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serous psammocarcinoma of the ovary: a case report and review of literature.
    Giordano G; Gnetti L; Milione M; Piccolo D; Soliani P
    Gynecol Oncol; 2005 Jan; 96(1):259-62. PubMed ID: 15589614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serous ovarian and primary peritoneal cancers: A comparative analysis of clinico-pathological features, molecular subtypes and treatment outcome.
    Gao B; Lindemann K; Anderson L; Fereday S; Hung J; Alsop K; Tothill RW; Gebski V; Kennedy C; Balleine RL; ; Harnett PR; Bowtell DD; DeFazio A
    Gynecol Oncol; 2016 Sep; 142(3):458-64. PubMed ID: 27444035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serous peritoneal psammocarcinoma with an aggressive course: a case and review of the literature.
    Bodnar L; Wcislo G; Górnas M; Gasowska-Bodnar A; Wiśniewski P; Stec R; Baranowski W; Szczylik C
    Ginekol Pol; 2009 Aug; 80(8):632-6. PubMed ID: 19824465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal implantations of papillary serous ovarian cystadenocarcinoma 13 days after initial laparoscopic treatment for a presumed benign ovarian cyst.
    Papoutsis D; Rodolakis A; Haidopoulos D; Sotiropoulou M; Antsaklis A
    Eur J Gynaecol Oncol; 2009; 30(1):103-5. PubMed ID: 19317271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytologic findings of psammocarcinoma in peritoneal washings.
    Pantanowitz L; Otis CN; Goulart RA
    Acta Cytol; 2009; 53(3):263-7. PubMed ID: 19534264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.